Search research articles
Contact Us
Filters
Showing results (51-60 of 66) with videos related to
Page
of 7
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 3, 2017
Density of Upper Respiratory Colonization With Streptococcus pneumoniae and Its Role in the Diagnosis of Pneumococcal Pneumonia Among Children Aged <5 Years in the PERCH Study
Henry C Baggett, Nora L Watson, Maria Deloria Knoll, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 3, 2017
Colonization Density of the Upper Respiratory Tract as a Predictor of Pneumonia-Haemophilus influenzae, Moraxella catarrhalis, Staphylococcus aureus, and Pneumocystis jirovecii
Daniel E Park, Henry C Baggett, Stephen R C Howie, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 3, 2017
Standardization of Laboratory Methods for the PERCH Study
Amanda J Driscoll, Ruth A Karron, Susan C Morpeth, et al.
American Journal of Human Genetics
|
May 31, 2016
Polymorphism in a lincRNA Associates with a Doubled Risk of Pneumococcal Bacteremia in Kenyan Children
, , Anna Rautanen, et al.
Annals of Internal Medicine
|
December 23, 2024
Anticoagulation Among Patients Hospitalized for COVID-19 : A Systematic Review and Prospective Meta-analysis
, Claire L Vale, Peter J Godolphin, et al.
The New England Journal of Medicine
|
February 25, 2021
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
, Anthony C Gordon, Paul R Mouncey, et al.
Intensive Care Medicine
|
July 12, 2021
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
Yaseen M Arabi, Anthony C Gordon, Lennie P G Derde, et al.
NEJM Evidence
|
February 6, 2024
A Randomized Trial of Nafamostat for Covid-19
Susan C Morpeth, Balasubramanian Venkatesh, James A Totterdell, et al.
JAMA
|
March 22, 2022
Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial
, Charlotte A Bradbury, Patrick R Lawler, et al.
Thorax
|
May 13, 2025
Tocilizumab, sarilumab and anakinra in critically ill patients with COVID-19: a randomised, controlled, open-label, adaptive platform trial
Lennie Derde, Anthony C Gordon, Paul R Mouncey, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 66) with videos related to
Sort By:
Page
of 7
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 3, 2017
Density of Upper Respiratory Colonization With Streptococcus pneumoniae and Its Role in the Diagnosis of Pneumococcal Pneumonia Among Children Aged <5 Years in the PERCH Study
Henry C Baggett, Nora L Watson, Maria Deloria Knoll, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 3, 2017
Colonization Density of the Upper Respiratory Tract as a Predictor of Pneumonia-Haemophilus influenzae, Moraxella catarrhalis, Staphylococcus aureus, and Pneumocystis jirovecii
Daniel E Park, Henry C Baggett, Stephen R C Howie, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 3, 2017
Standardization of Laboratory Methods for the PERCH Study
Amanda J Driscoll, Ruth A Karron, Susan C Morpeth, et al.
American Journal of Human Genetics
|
May 31, 2016
Polymorphism in a lincRNA Associates with a Doubled Risk of Pneumococcal Bacteremia in Kenyan Children
, , Anna Rautanen, et al.
Annals of Internal Medicine
|
December 23, 2024
Anticoagulation Among Patients Hospitalized for COVID-19 : A Systematic Review and Prospective Meta-analysis
, Claire L Vale, Peter J Godolphin, et al.
The New England Journal of Medicine
|
February 25, 2021
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
, Anthony C Gordon, Paul R Mouncey, et al.
Intensive Care Medicine
|
July 12, 2021
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
Yaseen M Arabi, Anthony C Gordon, Lennie P G Derde, et al.
NEJM Evidence
|
February 6, 2024
A Randomized Trial of Nafamostat for Covid-19
Susan C Morpeth, Balasubramanian Venkatesh, James A Totterdell, et al.
JAMA
|
March 22, 2022
Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial
, Charlotte A Bradbury, Patrick R Lawler, et al.
Thorax
|
May 13, 2025
Tocilizumab, sarilumab and anakinra in critically ill patients with COVID-19: a randomised, controlled, open-label, adaptive platform trial
Lennie Derde, Anthony C Gordon, Paul R Mouncey, et al.
Page
of 7